Dolibarr application versions v3.3.beta1_20121221 to v13.0.2 have an improper user access control vulnerability allowing account takeover. Learn the impact, mitigation steps, and prevention.
Dolibarr application versions v3.3.beta1_20121221 to v13.0.2 allow admin users to change other user's details without validating the existing "Login" name, leading to an account takeover vulnerability.
Understanding CVE-2021-25956
This CVE describes an improper user access control issue in Dolibarr application, potentially resulting in a complete account takeover.
What is CVE-2021-25956?
The vulnerability in Dolibarr application versions v3.3.beta1_20121221 to v13.0.2 allows admin users to modify user details without validating the existing "Login" name, enabling a complete account takeover.
The Impact of CVE-2021-25956
Exploiting this vulnerability could lead to an attacker taking complete control of a victim user's account, compromising confidentiality and potentially causing severe integrity damage.
Technical Details of CVE-2021-25956
This section provides more in-depth technical insights into the CVE.
Vulnerability Description
The flaw allows admin users to overwrite passwords for victim users with similar login names, enabling unauthorized access to their accounts.
Affected Systems and Versions
Dolibarr versions v3.3.beta1_20121221 to v13.0.2 are affected by this vulnerability.
Exploitation Mechanism
Admin users with high privileges can exploit this issue by changing other user's details without proper validation of the existing "Login" name.
Mitigation and Prevention
To secure systems against CVE-2021-25956, immediate actions and long-term security practices are crucial.
Immediate Steps to Take
Users are advised to update Dolibarr to version 14.0.0 to mitigate this vulnerability effectively.
Long-Term Security Practices
Implement strict user access control mechanisms, regularly update software, and conduct security training to prevent similar vulnerabilities.
Patching and Updates
Regularly check for security patches and updates from Dolibarr to stay protected against evolving threats.